| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.007 | 1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.0079 | 1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |